0001209191-20-041277.txt : 20200706
0001209191-20-041277.hdr.sgml : 20200706
20200706192943
ACCESSION NUMBER: 0001209191-20-041277
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200701
FILED AS OF DATE: 20200706
DATE AS OF CHANGE: 20200706
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LOBERG MICHAEL D
CENTRAL INDEX KEY: 0001233414
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39045
FILM NUMBER: 201014849
MAIL ADDRESS:
STREET 1: C/O ARQULE, INC.
STREET 2: 1 WALL STREET, 6TH FLOOR
CITY: BURLINGTON
STATE: MA
ZIP: 01803
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IGM Biosciences, Inc.
CENTRAL INDEX KEY: 0001496323
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 770349194
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 325 E MIDDLEFIELD ROAD
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
BUSINESS PHONE: 650-965-7873
MAIL ADDRESS:
STREET 1: 325 E MIDDLEFIELD ROAD
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
FORMER COMPANY:
FORMER CONFORMED NAME: Palingen, Inc.
DATE OF NAME CHANGE: 20100712
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-07-01
0
0001496323
IGM Biosciences, Inc.
IGMS
0001233414
LOBERG MICHAEL D
C/O IGM BIOSCIENCES, INC.
325 E. MIDDLEFIELD ROAD
MOUNTAIN VIEW
CA
94043
1
0
0
0
Common Stock
2020-04-09
5
G
0
E
39803
0.00
D
535
D
Common Stock
2020-04-09
5
G
0
E
39803
0.00
A
39803
I
See footnote
Common Stock
2020-04-17
5
G
0
E
39803
0.00
D
0
I
See footnote
Common Stock
2020-04-17
5
G
0
E
39803
0.00
A
39803
I
See footnote
Common Stock
2020-06-04
5
G
0
E
535
0.00
D
0
D
Common Stock
2020-06-04
5
G
0
E
535
0.00
A
535
I
See footnote
Common Stock
2020-07-01
4
A
0
535
0.00
A
535
D
The shares are held by the Revocable Deed of Trust of Michael D. Loberg (Michael and Melinda Loberg, Trustees), of which Reporting Person and his spouse serve as trustees.
The shares are held by the Michael D. Loberg Qualified Annuity Interest Trust VII (Michael and Melinda Loberg, Trustees), of which Reporting Person and his spouse serve as trustees.
Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The amount reflects payment of a quarterly retainer in common stock pursuant to the Issuer's Outside Director Compensation Policy.
/s/ Misbah Tahir, by power of attorney
2020-07-06